Novanta（1GSN）株式概要ノバンタ社は、その子会社とともに、精密医療、精密製造、医療ソリューション、ロボット工学および自動化ソリューション、高度外科手術ソリューションを米国内外で提供している。 詳細1GSN ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長3/6過去の実績1/6財務の健全性6/6配当金0/6報酬収益は年間33.86%増加すると予測されています リスク分析財務結果に影響を与える大きな一時的項目 すべてのリスクチェックを見る1GSN Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€118.002.2% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture01b2016201920222025202620282031Revenue US$1.3bEarnings US$73.1mAdvancedSet Fair ValueView all narrativesNovanta Inc. 競合他社JenoptikSymbol: XTRA:JENMarket cap: €2.0bBaslerSymbol: XTRA:BSLMarket cap: €719.5mStemmer ImagingSymbol: HMSE:S9IMarket cap: €393.3mFORTEC ElektronikSymbol: XTRA:FEVMarket cap: €34.5m価格と性能株価の高値、安値、推移の概要Novanta過去の株価現在の株価US$118.0052週高値US$123.0052週安値US$84.50ベータ1.621ヶ月の変化16.83%3ヶ月変化5.36%1年変化12.38%3年間の変化-20.81%5年間の変化11.32%IPOからの変化31,199.73%最新ニュースお知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375お知らせ • Nov 04Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million. For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million. Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches.最新情報をもっと見るRecent updatesお知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375お知らせ • Nov 04Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million. For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million. Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches.お知らせ • Oct 08Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025お知らせ • Sep 19Novanta Inc. Announces the Resignation of Barbara Hulit as Member of the Board of Directors and the Audit Committee and Environmental, Social and Governance Committee of the Board, Effective November 1, 2025Novanta Inc. announced that on September 15, 2025, Barbara Hulit resigned as a member of the Board of Directors of the company and the Audit Committee and Environmental, Social and Governance Committee of the Board, effective November 1, 2025. Ms. Hulit’s decision to resign was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.お知らせ • Aug 05Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2025Novanta Inc. provided earnings guidance for the third quarter and full year 2025. For the quarter, the Company expects GAAP revenue of approximately $244 million to $247 million. For the full year 2025, the Company expects GAAP revenue of approximately $970 million to $985 million.お知らせ • Jul 13Novanta Inc. Announces Departure of Michele D. Welsh, General Counsel and Corporate Secretary, Effective on July 18, 2025On July 8, 2025, Novanta Inc. (the Company) announced that Michele D. Welsh, General Counsel and Corporate Secretary of the Company, would no longer serve in those positions, effective on July 18, 2025, or such earlier date as may be agreed between Ms. Welsh and the Company. There are no changes to the severance that Ms. Welsh is entitled to receive pursuant to Section 4(a)(iv) of Ms. Welsh’s employment agreement dated July 11, 2022.お知らせ • Jul 09Novanta Inc. to Report Q2, 2025 Results on Aug 05, 2025Novanta Inc. announced that they will report Q2, 2025 results on Aug 05, 2025お知らせ • May 07Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million.Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million on April 8, 2025. A an initial cash payment of €60.6 million ($66.4 million), subject to customary closing and net working capital adjustments. The purchase includes up to €20.0 million ($21.9 million) in contingent consideration payable upon the achievement of certain revenue targets through December 2027. In addition, the Company has granted equity totaling €9.0 million ($9.9 million) to Keonn employees. The Keonn acquisition will be included in the Medical Solutions reportable segment. On April 8, 2025, Novanta drew down on revolving credit facility under the Senior Credit Facilities to fund the acquisition of Keonn Technologies, S.L. The acquisition was financed with cash on-hand and borrowings under Novanta's revolving credit facility. Novanta Inc. (NasdaqGS:NOVT) completed the acquisition of Keonn Technologies, S.L. on April 8, 2025.お知らせ • May 06Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2025Novanta Inc. provided earnings guidance for the second quarter of 2025. For the quarter, the Company expects GAAP revenue of approximately $230 million to $240 million.お知らせ • Apr 28Novanta Inc., Annual General Meeting, May 29, 2025Novanta Inc., Annual General Meeting, May 29, 2025.お知らせ • Apr 09Novanta Inc. to Report Q1, 2025 Results on May 06, 2025Novanta Inc. announced that they will report Q1, 2025 results on May 06, 2025お知らせ • Feb 26Novanta Inc. Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025Novanta Inc. provided earnings guidance for the first quarter of 2025 and full year 2025. For the quarter, the company expects GAAP revenue of approximately $232 million to $236 million. For the year, the company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approximately 5% year-over-year.お知らせ • Jan 29Novanta Inc. to Report Q4, 2024 Results on Feb 25, 2025Novanta Inc. announced that they will report Q4, 2024 results on Feb 25, 2025Recent Insider Transactions • Nov 14CEO & Chairman of the Board recently sold €1.3m worth of stockOn the 11th of November, Matthijs Glastra sold around 8k shares on-market at roughly €169 per share. This transaction amounted to 5.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Matthijs' only on-market trade for the last 12 months.Reported Earnings • Nov 08Third quarter 2024 earnings released: EPS: US$0.53 (vs US$0.59 in 3Q 2023)Third quarter 2024 results: EPS: US$0.53 (down from US$0.59 in 3Q 2023). Revenue: US$244.4m (up 10% from 3Q 2023). Net income: US$19.2m (down 9.6% from 3Q 2023). Profit margin: 7.9% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.お知らせ • Nov 05Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 and Revenue Guidance for the Year 2025Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2024 and revenue guidance for the year 2025. For the fourth quarter of 2024, the company expects GAAP revenue of approximately $237 million to $242 million. For the full year 2024, the company expects GAAP revenue of approximately $948 million to $953 million. The company expects organic revenue growth of up to 10% in 2025 compared to 2024.お知らせ • Oct 09Novanta Inc. to Report Q3, 2024 Results on Nov 05, 2024Novanta Inc. announced that they will report Q3, 2024 results on Nov 05, 2024お知らせ • Aug 24Novanta Inc. Announces Executive ChangesOn August 22, 2024, John Burke, formerly Vice President of Global Accounting for Novanta Inc. (company) was appointed Chief Accounting Officer of the company and assumed the role of principal accounting officer. Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024. Mr. Chang, who served thirteen years in the role, will serve as an advisor to the Chief Financial Officer until his anticipated departure from the Company on February 28, 2025, and will assist with the transition of the Chief Accounting Officer role. Mr. Burke, age 43, has been it’s Vice President of Global Accounting since 2021, and previously served as Vice President of Accounting from 2017 to 2021 and Assistant Corporate Controller from 2011 to 2017. Prior to joining the company, Mr. Burke worked as the Manager of Technical Accounting and Reporting at MilliporeSigma (formerly known as Millipore Corporation), and prior to that, as an audit manager in the Boston office of PricewaterhouseCoopers LLP. Mr. Burke is a Certified Public Accountant and has a Bachelor of Business Administration degree in Accounting from the University of Massachusetts-Amherst.Reported Earnings • Aug 07Second quarter 2024 earnings released: EPS: US$0.38 (vs US$0.58 in 2Q 2023)Second quarter 2024 results: EPS: US$0.38 (down from US$0.58 in 2Q 2023). Revenue: US$235.9m (up 2.8% from 2Q 2023). Net income: US$13.8m (down 34% from 2Q 2023). Profit margin: 5.8% (down from 9.1% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 07Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024Novanta Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, Company expects GAAP revenue of approximately $241 millionto $244 million. For the year, the company expects GAAP revenue of approximately $975 million, representing reported revenue growth of greater than 10%.お知らせ • Jul 10Novanta Inc. to Report Q2, 2024 Results on Aug 06, 2024Novanta Inc. announced that they will report Q2, 2024 results on Aug 06, 2024お知らせ • May 08Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2024Novanta Inc. provided earnings guidance for the second quarter of 2024. For the quarter, the Company expects GAAP revenue of approximately $230 million to $235 million.Reported Earnings • May 07First quarter 2024 earnings released: EPS: US$0.41 (vs US$0.51 in 1Q 2023)First quarter 2024 results: EPS: US$0.41 (down from US$0.51 in 1Q 2023). Revenue: US$230.9m (up 5.4% from 1Q 2023). Net income: US$14.7m (down 20% from 1Q 2023). Profit margin: 6.4% (down from 8.3% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 13% per year.お知らせ • Apr 10Novanta Inc. to Report Q1, 2024 Results on May 07, 2024Novanta Inc. announced that they will report Q1, 2024 results at 12:30 PM, US Eastern Standard Time on May 07, 2024お知らせ • Mar 01Novanta Inc., Annual General Meeting, May 08, 2024Novanta Inc., Annual General Meeting, May 08, 2024.お知らせ • Feb 29Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024Novanta Inc. provided revenue guidance for the first quarter and full year of 2024. For the quarter, company expects GAAP revenue of approximately $225 million to $230 million. For the year, Company expects GAAP revenue of approximately $975 million to $1 billion.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: US$2.03 (vs US$2.08 in FY 2022)Full year 2023 results: EPS: US$2.03 (down from US$2.08 in FY 2022). Revenue: US$881.7m (up 2.4% from FY 2022). Net income: US$72.9m (down 1.6% from FY 2022). Profit margin: 8.3% (down from 8.6% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 30Novanta Inc. to Report Q4, 2023 Results on Feb 28, 2024Novanta Inc. announced that they will report Q4, 2023 results on Feb 28, 2024Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €132, the stock trades at a forward P/E ratio of 63x. Average forward P/E is 11x in the Electronic industry in Germany. Total returns to shareholders of 38% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €86.58 per share.お知らせ • Nov 09Novanta Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Full Year 2023Novanta Inc. provides revenue guidance for the fourth quarter of 2023 and full year 2023. For the fourth quarter of 2023, the Company expects GAAP revenue of approximately $208 million to $212 million. For the full year 2023, the Company expects GAAP revenue of approximately $878 million to $882 million.Reported Earnings • Nov 08Third quarter 2023 earnings released: EPS: US$0.59 (vs US$0.63 in 3Q 2022)Third quarter 2023 results: EPS: US$0.59 (down from US$0.63 in 3Q 2022). Revenue: US$221.5m (flat on 3Q 2022). Net income: US$21.2m (down 5.6% from 3Q 2022). Profit margin: 9.6% (in line with 3Q 2022). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 11Novanta Inc. to Report Q3, 2023 Results on Nov 07, 2023Novanta Inc. announced that they will report Q3, 2023 results on Nov 07, 2023Reported Earnings • Aug 09Second quarter 2023 earnings released: EPS: US$0.58 (vs US$0.49 in 2Q 2022)Second quarter 2023 results: EPS: US$0.58 (up from US$0.49 in 2Q 2022). Revenue: US$229.5m (up 6.6% from 2Q 2022). Net income: US$20.9m (up 20% from 2Q 2022). Profit margin: 9.1% (up from 8.1% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 09Second quarter 2023 earnings released: EPS: US$0.58 (vs US$0.49 in 2Q 2022)Second quarter 2023 results: EPS: US$0.58 (up from US$0.49 in 2Q 2022). Revenue: US$229.5m (up 6.6% from 2Q 2022). Net income: US$20.9m (up 20% from 2Q 2022). Profit margin: 9.1% (up from 8.1% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 09Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2023Novanta Inc. provided earnings guidance for the third quarter and full year 2023. For the quarter, the Company expects GAAP revenue of approximately $221 million to $224 million.For the full year 2023, the Company expects GAAP revenue of approximately $892 million to $902 million.お知らせ • Jul 12Novanta Inc. to Report Q2, 2023 Results on Aug 08, 2023Novanta Inc. announced that they will report Q2, 2023 results at 9:30 AM, US Eastern Standard Time on Aug 08, 2023お知らせ • May 10Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2023Novanta Inc. provided earnings guidance for the second quarter of 2023. For the quarter, the company expects GAAP revenue of approximately $222 million to $225 million.Reported Earnings • May 10First quarter 2023 earnings released: EPS: US$0.51 (vs US$0.53 in 1Q 2022)First quarter 2023 results: EPS: US$0.51 (down from US$0.53 in 1Q 2022). Revenue: US$219.1m (up 7.3% from 1Q 2022). Net income: US$18.3m (down 2.9% from 1Q 2022). Profit margin: 8.3% (down from 9.2% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 22% per year.Reported Earnings • Mar 02Full year 2022 earnings released: EPS: US$2.08 (vs US$1.42 in FY 2021)Full year 2022 results: EPS: US$2.08 (up from US$1.42 in FY 2021). Revenue: US$860.9m (up 22% from FY 2021). Net income: US$74.1m (up 47% from FY 2021). Profit margin: 8.6% (up from 7.1% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 18% per year.お知らせ • Feb 02Novanta Inc. to Report Q4, 2022 Results on Mar 01, 2023Novanta Inc. announced that they will report Q4, 2022 results on Mar 01, 2023Board Change • Nov 16High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Barbara Hulit was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 09Third quarter 2022 earnings released: EPS: US$0.63 (vs US$0.38 in 3Q 2021)Third quarter 2022 results: EPS: US$0.63 (up from US$0.38 in 3Q 2021). Revenue: US$223.0m (up 26% from 3Q 2021). Net income: US$22.5m (up 65% from 3Q 2021). Profit margin: 10% (up from 7.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 09Novanta Inc. Provides Financial Guidance for the Fourth Quarter and Full Year 2022Novanta Inc. provided financial guidance for the fourth quarter and full year 2022. For the fourth quarter of 2022, the Company expects GAAP revenue of approximately $215 million to $217 million, demonstrating reported growth of 8% to 9%. For the full year 2022, the Company expects GAAP revenue of approximately $857 million to $859 million, demonstrating reported growth of 21% to 22%.お知らせ • Oct 22Novan, Inc., Epi Health and MC2 Therapeutics Present New Data in Multiple Posters Highlighting Wynzora’s Unique Pad Technology At the 42Nd Annual Fall Clinical Dermatology ConferenceNovan Inc. EPI Health and MC2 Therapeutics announced positive data demonstrating the impact of PAD Technology™ in WYNZORA® Cream in three posters featured at the 42nd Annual Fall Clinical Dermatology Conference® taking place October 20-23, 2022, in Las Vegas, NV. PAD Technology™, as explained in one of the posters, is a proprietary topical formulation and drug delivery system that allows CAL and BDP to co-exist in an aqueous environment (WYNZORA® Cream), for the first time.1 These active ingredients are stable at different pH levels, and without the unique properties of PAD Technology™ could not co-exist in a water-based formulation. In a second poster, diffusion of these active ingredients through human epidermis was investigated in an in vitro Franz diffusion study. This demonstrated that consistently higher amounts of CAL and BDP diffused through the epidermis with the PAD Technology™ based cream compared with the CAL/BDP topical suspension. The results were statistically significant in favor of CAL/BDP cream vs. CAL/BDP topical suspension (p<0.05) at all time points for both actives. Finally, WYNZORA® cream was compared to CAL/BDP topical suspension in a deposition study in 10 healthy human volunteers using tape strips taken at 1, 2, 4 and 8 hours. The results showed that more BDP was delivered to the stratum corneum and epidermis with the PAD Technology™-driven cream formulation than with the CAL/BDP topical suspension at every time point. EPI Health, a Novan company, and MC2 Therapeutics jointly market MC2 Therapeutics' WYNZORA® (calcipotriene and betamethasone dipropionate) Cream in the US, a once-daily aqueous cream that combines the benefits of a high potency steroid plus Vitamin D for the treatment of plaque psoriasis. WYNZORA® Cream demonstrates a rapid onset of action with results seen in efficacy, scale and itch as early as 1 week and continued improvement at 8 weeks.2,3 Under a Promotion and Collaboration Agreement between EPI Health and MC2 Therapeutics, EPI Health has exclusive detailing and distribution rights and the right to jointly with MC2 Therapeutics engage in promotional, regulatory and certain commercialization activities for WYNZORA® Cream in the United States.お知らせ • Oct 11Novanta Inc. to Report Q3, 2022 Results on Nov 08, 2022Novanta Inc. announced that they will report Q3, 2022 results on Nov 08, 2022Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: US$0.49 (vs US$0.33 in 2Q 2021)Second quarter 2022 results: EPS: US$0.49 (up from US$0.33 in 2Q 2021). Revenue: US$215.4m (up 29% from 2Q 2021). Net income: US$17.5m (up 50% from 2Q 2021). Profit margin: 8.1% (up from 7.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11%, compared to a 21% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 10Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022Novanta Inc. provided earnings guidance for the third quarter and full year 2022. For the quarter, the company expects GAAP revenue of approximately $214 million to $216 million, demonstrating reported growth of 20% to 22%.For the year, the company expects GAAP revenue of approximately $848 million to $852 million, demonstrating reported growth of 20% to 21%.Board Change • Aug 01High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Barbara Hulit was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jul 28Novanta Inc. Announces Director ChangesOn July 26, 2022, Ira J. Lamel resigned as a director of Novanta Inc. effective immediately. On July 26, 2022, the Board of Directors of the Company elected Barbara B. Hulit to the Board to fill an existing vacancy, effective July 26, 2022. Ms. Hulit will also serve as a member of the Environmental, Social and Governance Committee of the Board.お知らせ • Jul 12+ 1 more updateNovanta Inc. to Report Q2, 2022 Results on Aug 09, 2022Novanta Inc. announced that they will report Q2, 2022 results on Aug 09, 2022Board Change • Jul 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Darlene J. Solomon was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 29Novanta Inc. Announces Directorate ChangesNovanta Inc. announced that on June 28, 2022, Brian King resigned as a director of the company, effective immediately. On June 28, 2022, the Board of Directors of the Company elected Darlene J. S. Solomon, Ph.D., to the Board to fill an existing vacancy, effective June 28, 2022. Ms. Solomon will also serve as a member of the Compensation Committee of the Board.お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2022Novanta Inc. provided earnings guidance for the second quarter of 2022. The Company expects GAAP revenue of approximately $205 million to $213 million, demonstrating reported growth of 22% to 27%.Reported Earnings • May 11First quarter 2022 earnings released: EPS: US$0.53 (vs US$0.32 in 1Q 2021)First quarter 2022 results: EPS: US$0.53 (up from US$0.32 in 1Q 2021). Revenue: US$204.2m (up 26% from 1Q 2021). Net income: US$18.8m (up 66% from 1Q 2021). Profit margin: 9.2% (up from 7.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 27% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Apr 12Novanta Inc. to Report Q1, 2022 Results on May 10, 2022Novanta Inc. announced that they will report Q1, 2022 results on May 10, 2022お知らせ • Mar 04Novanta Inc., Annual General Meeting, May 12, 2022Novanta Inc., Annual General Meeting, May 12, 2022.Reported Earnings • Mar 03Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: US$1.42 (up from US$1.27 in FY 2020). Revenue: US$706.8m (up 20% from FY 2020). Net income: US$50.3m (up 13% from FY 2020). Profit margin: 7.1% (down from 7.5% in FY 2020). Revenue exceeded analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 17%, compared to a 23% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.お知らせ • Mar 03Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year 2022Novanta Inc. provided revenue guidance for the first quarter and full year 2022. For the quarter, the Company expects GAAP revenue to be in the range of approximately $192 million to $200 million. For the full year 2022, the Company expects GAAP revenue to be in the range of approximately $825 million to $845 million.Reported Earnings • Nov 11Third quarter 2021 earnings released: EPS US$0.38 (vs US$0.23 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$177.7m (up 24% from 3Q 2020). Net income: US$13.6m (up 65% from 3Q 2020). Profit margin: 7.7% (up from 5.8% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.Reported Earnings • Aug 11Second quarter 2021 earnings released: EPS US$0.33 (vs US$0.33 in 2Q 2020)The company reported a mediocre second quarter result with weaker profit margins, although earnings were flat and revenues improved. Second quarter 2021 results: Revenue: US$167.5m (up 16% from 2Q 2020). Net income: US$11.7m (flat on 2Q 2020). Profit margin: 7.0% (down from 8.1% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 20Novanta Inc. (NasdaqGS:NOVT) entered into an agreement to acquire ATI Industrial Automation, Inc. for approximately $170 million.Novanta Inc. (NasdaqGS:NOVT) entered into an agreement to acquire ATI Industrial Automation, Inc. for approximately $170 million on July 19, 2021. The consideration of $172 million will be paid upfront in cash and additional contingent cash payments associated with 2021 financial performance. The acquisition will be financed using available cash and Novanta's revolving credit facility. ATI's expected 2021 revenue will be greater than $70 million on a full year basis. ATI's actual revenue and profit contribution to Novanta's 2021 financial results will depend on the ultimate date of the closing of the transaction, among other factors. The transaction is subject to customary closing conditions, including regulatory approvals and termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2021. The acquisition is expected to be accretive to Novanta's free cash flow and non-GAAP earnings per share on a full year basis. John Arendale, Jeff Perkins, Brandt Carr, Jenson Dunn and Caroline Inglesby of Harris Williams LLC acted as financial advisor to ATI Industrial Automation.Reported Earnings • May 13First quarter 2021 earnings released: EPS US$0.32 (vs US$0.34 in 1Q 2020)The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: US$162.6m (up 4.6% from 1Q 2020). Net income: US$11.3m (down 5.3% from 1Q 2020). Profit margin: 7.0% (down from 7.7% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2021Novanta Inc. provided earnings guidance for the second quarter and full year 2021. For the second quarter of 2021, the Company expects GAAP revenue of approximately $162 million to $165 million. For the full year 2021, the Company expects GAAP revenue of approximately $645 million to $655 million.Reported Earnings • Mar 03Full year 2020 earnings released: EPS US$1.27 (vs US$1.16 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: US$590.6m (down 5.7% from FY 2019). Net income: US$44.5m (up 9.2% from FY 2019). Profit margin: 7.5% (up from 6.5% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.Analyst Estimate Surprise Post Earnings • Mar 03Revenue beats expectationsRevenue exceeded analyst estimates by 0.08%. Over the next year, revenue is forecast to grow 8.7%, compared to a 17% growth forecast for the Electronic industry in Germany.お知らせ • Feb 27Novanta Inc., Annual General Meeting, May 13, 2021Novanta Inc., Annual General Meeting, May 13, 2021.Is New 90 Day High Low • Feb 13New 90-day high: €117The company is up 22% from its price of €96.00 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €34.81 per share.お知らせ • Feb 03Novanta Inc. to Report Q4, 2020 Results on Mar 01, 2021Novanta Inc. announced that they will report Q4, 2020 results on Mar 01, 2021Is New 90 Day High Low • Jan 26New 90-day high: €110The company is up 15% from its price of €95.50 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.26 per share.Is New 90 Day High Low • Jan 09New 90-day high: €105The company is up 9.0% from its price of €96.50 on 09 October 2020. The German market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Electronic industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €34.77 per share.お知らせ • Dec 23Novan, Inc. Enters into a Master Services Agreement (MSA) with CatalentNovan, Inc. announced it has entered into a Master Services Agreement (MSA) with Catalent, which will include support of chemistry, manufacturing and control (CMC) activities and development of an intranasal formulation of berdazimer sodium for use in the Company’s coronavirus (COVID-19) program. Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Catalent’s advanced formulation development and manufacturing spans a range of technologies, along with integrated downstream clinical development and commercial supply solutions. Novan initiated in vitro assessments of its NITRICIL™ platform against the novel SARS-CoV-2 coronavirus, targeting the reduction of viral burden in differentiated normal human bronchial epithelial cells. The studies were conducted at the Institute for Antiviral Research at Utah State University, and these results demonstrated the first instance of an antiviral effect from a nitric oxide-based medicine in a 3-D tissue model that has similar structure to the human airway epithelium. The results from the in vitro assessment of concentrations as low as 0.75 mg/mL demonstrated that berdazimer sodium reduced 90% of virus after repeat dosing, once daily. Based on the scientific literature and data available to-date with berdazimer sodium and Novan’s product candidate SB206, Novan believes that nitric oxide may inhibit viral replication by disrupting protein function critical for viral replication and infection through generation of reactive intermediates. Following the completion of preclinical studies, Novan is targeting filing a potential IND application with the U.S. Food and Drug Administration and, subject to obtaining additional funding, targets initiating human clinical trials in the second half of 2021.お知らせ • Dec 13Novanta Inc. Elects Katherine A. Owen to the Board, Effective February 24, 2021On December 8, 2020, the Board of Directors of Novanta Inc. elected Katherine A. Owen to the Board, effective February 24, 2021, to fill an existing vacancy on the Board.Analyst Estimate Surprise Post Earnings • Nov 11Revenue beats expectationsRevenue exceeded analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 4.2%, compared to a 24% growth forecast for the Electronic industry in Germany.Reported Earnings • Nov 11Third quarter 2020 earnings released: EPS US$0.23The company reported a poor third quarter result with weaker earnings and revenues, although profit margins were flat. Third quarter 2020 results: Revenue: US$142.9m (down 7.2% from 3Q 2019). Net income: US$8.26m (down 7.5% from 3Q 2019). Profit margin: 5.8% (in line with 3Q 2019). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Is New 90 Day High Low • Nov 07New 90-day high: €100.00The company is up 4.0% from its price of €96.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €35.48 per share.お知らせ • Oct 15Novanta Inc. to Report Q3, 2020 Results on Nov 10, 2020Novanta Inc. announced that they will report Q3, 2020 results at 11:59 AM, GMT Standard Time on Nov 10, 2020お知らせ • Aug 24Novanta Inc. Not Able to Reliably Estimate the Future Impact on its Operations and Other Financial Results for the Full Year 2020Novanta Inc. announced that due to the impact of the COVID-19 pandemic, the uncertain duration and scope of the pandemic, and the uncertain timing of the global public health and economic recovery, the Company is not able at this time to reliably estimate the future impact on its operations and other financial results for the full year 2020.お知らせ • Jul 17Novanta Inc. to Report Q2, 2020 Results on Aug 06, 2020Novanta Inc. announced that they will report Q2, 2020 results at 11:59 AM, GMT Standard Time on Aug 06, 2020お知らせ • Jul 02Novanta Inc.(NasdaqGS:NOVT) dropped from Russell 2000 Dynamic IndexNovanta Inc.(NasdaqGS:NOVT) dropped from Russell 2000 Dynamic Index株主還元1GSNDE ElectronicDE 市場7D15.7%14.8%-0.02%1Y12.4%80.7%0.1%株主還元を見る業界別リターン: 1GSN過去 1 年間で80.7 % の収益を上げたGerman Electronic業界を下回りました。リターン対市場: 1GSN過去 1 年間で0.1 % の収益を上げたGerman市場を上回りました。価格変動Is 1GSN's price volatile compared to industry and market?1GSN volatility1GSN Average Weekly Movement6.5%Electronic Industry Average Movement8.3%Market Average Movement6.0%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.6%安定した株価: 1GSN 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 1GSNの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19683,000Matthijs Glastrawww.novanta.comノバンタ社は、その子会社とともに、精密医療、精密製造、医療ソリューション、ロボット工学とオートメーション・ソリューション、先進手術ソリューションを米国内外で提供している。オートメーション・イネーブリング・テクノロジーズとメディカル・ソリューションズの2つのセグメントで事業を展開している。精密医療・製造部門では、レーザービーム伝送コンポーネント、レーザービーム伝送ソリューション、CO2レーザー、固体レーザー、超高速レーザー、光学式・誘導式エンコーダー、精密モーター、一体型ステッピングモーター、サーボドライブ、モーション・コントロール・ソリューション、インテリジェント・ロボット・エンド・オブ・アーム・テクノロジー・ソリューション、エアベアリング・スピンドルの設計、製造、販売を行っている。このセグメントは、高度な産業プロセス、高度な産業用および医療用ロボット、その他の医療およびライフサイエンス・オートメーション・アプリケーション、眼科アプリケーションなどの医療用レーザー処置に対応している。メディカル・ソリューション部門は、医療用気腹器、ポンプ、関連ディスポーザブル、レーザービーム伝送ソリューション、ビデオ処理、ストリーミング、キャプチャ、マシンビジョン技術、RFID（無線自動識別）技術、バーコード識別技術、サーマルチャートレコーダ、光・色計測技術、タッチパネルディスプレイ、高度モーションコントロールソリューションなど、幅広い医療グレードの技術を提供している。Cambridge Technology、Synrad、Laser Quantum、ARGES、WOM、NDS、Med X Change、Reach Technology、JADAK、ThingMagic、Photo Research、General Scanning、ATI Industrial Automation、Celera Motion、IMS、MicroE、Applimotion、Zettlex、Ingenia、Westwindのブランドで直販および代理店を通じて製品を販売している。同社は以前はGSI Group, Inc.として知られていたが、2016年5月にNovanta Inc.に社名を変更した。ノバンタ・インクは1968年に法人化され、マサチューセッツ州ベッドフォードに本社を置いている。もっと見るNovanta Inc. 基礎のまとめNovanta の収益と売上を時価総額と比較するとどうか。1GSN 基礎統計学時価総額€4.21b収益（TTM）€45.85m売上高(TTM)€835.28m90.2xPER（株価収益率4.9xP/Sレシオ1GSN は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1GSN 損益計算書（TTM）収益US$980.60m売上原価US$545.32m売上総利益US$435.28mその他の費用US$381.46m収益US$53.83m直近の収益報告Dec 31, 2025次回決算日May 11, 2026一株当たり利益（EPS）1.51グロス・マージン44.39%純利益率5.49%有利子負債／自己資本比率19.1%1GSN の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 10:59終値2026/05/07 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Novanta Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Robert MasonBairdQuinn FredricksonBairdAndrew BuscagliaBerenberg5 その他のアナリストを表示
お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026
お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.
お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.
お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026
お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375
お知らせ • Nov 04Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million. For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million. Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches.
お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026
お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.
お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.
お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026
お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375
お知らせ • Nov 04Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million. For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million. Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches.
お知らせ • Oct 08Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025
お知らせ • Sep 19Novanta Inc. Announces the Resignation of Barbara Hulit as Member of the Board of Directors and the Audit Committee and Environmental, Social and Governance Committee of the Board, Effective November 1, 2025Novanta Inc. announced that on September 15, 2025, Barbara Hulit resigned as a member of the Board of Directors of the company and the Audit Committee and Environmental, Social and Governance Committee of the Board, effective November 1, 2025. Ms. Hulit’s decision to resign was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
お知らせ • Aug 05Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2025Novanta Inc. provided earnings guidance for the third quarter and full year 2025. For the quarter, the Company expects GAAP revenue of approximately $244 million to $247 million. For the full year 2025, the Company expects GAAP revenue of approximately $970 million to $985 million.
お知らせ • Jul 13Novanta Inc. Announces Departure of Michele D. Welsh, General Counsel and Corporate Secretary, Effective on July 18, 2025On July 8, 2025, Novanta Inc. (the Company) announced that Michele D. Welsh, General Counsel and Corporate Secretary of the Company, would no longer serve in those positions, effective on July 18, 2025, or such earlier date as may be agreed between Ms. Welsh and the Company. There are no changes to the severance that Ms. Welsh is entitled to receive pursuant to Section 4(a)(iv) of Ms. Welsh’s employment agreement dated July 11, 2022.
お知らせ • Jul 09Novanta Inc. to Report Q2, 2025 Results on Aug 05, 2025Novanta Inc. announced that they will report Q2, 2025 results on Aug 05, 2025
お知らせ • May 07Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million.Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million on April 8, 2025. A an initial cash payment of €60.6 million ($66.4 million), subject to customary closing and net working capital adjustments. The purchase includes up to €20.0 million ($21.9 million) in contingent consideration payable upon the achievement of certain revenue targets through December 2027. In addition, the Company has granted equity totaling €9.0 million ($9.9 million) to Keonn employees. The Keonn acquisition will be included in the Medical Solutions reportable segment. On April 8, 2025, Novanta drew down on revolving credit facility under the Senior Credit Facilities to fund the acquisition of Keonn Technologies, S.L. The acquisition was financed with cash on-hand and borrowings under Novanta's revolving credit facility. Novanta Inc. (NasdaqGS:NOVT) completed the acquisition of Keonn Technologies, S.L. on April 8, 2025.
お知らせ • May 06Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2025Novanta Inc. provided earnings guidance for the second quarter of 2025. For the quarter, the Company expects GAAP revenue of approximately $230 million to $240 million.
お知らせ • Apr 28Novanta Inc., Annual General Meeting, May 29, 2025Novanta Inc., Annual General Meeting, May 29, 2025.
お知らせ • Apr 09Novanta Inc. to Report Q1, 2025 Results on May 06, 2025Novanta Inc. announced that they will report Q1, 2025 results on May 06, 2025
お知らせ • Feb 26Novanta Inc. Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025Novanta Inc. provided earnings guidance for the first quarter of 2025 and full year 2025. For the quarter, the company expects GAAP revenue of approximately $232 million to $236 million. For the year, the company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approximately 5% year-over-year.
お知らせ • Jan 29Novanta Inc. to Report Q4, 2024 Results on Feb 25, 2025Novanta Inc. announced that they will report Q4, 2024 results on Feb 25, 2025
Recent Insider Transactions • Nov 14CEO & Chairman of the Board recently sold €1.3m worth of stockOn the 11th of November, Matthijs Glastra sold around 8k shares on-market at roughly €169 per share. This transaction amounted to 5.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Matthijs' only on-market trade for the last 12 months.
Reported Earnings • Nov 08Third quarter 2024 earnings released: EPS: US$0.53 (vs US$0.59 in 3Q 2023)Third quarter 2024 results: EPS: US$0.53 (down from US$0.59 in 3Q 2023). Revenue: US$244.4m (up 10% from 3Q 2023). Net income: US$19.2m (down 9.6% from 3Q 2023). Profit margin: 7.9% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Nov 05Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 and Revenue Guidance for the Year 2025Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2024 and revenue guidance for the year 2025. For the fourth quarter of 2024, the company expects GAAP revenue of approximately $237 million to $242 million. For the full year 2024, the company expects GAAP revenue of approximately $948 million to $953 million. The company expects organic revenue growth of up to 10% in 2025 compared to 2024.
お知らせ • Oct 09Novanta Inc. to Report Q3, 2024 Results on Nov 05, 2024Novanta Inc. announced that they will report Q3, 2024 results on Nov 05, 2024
お知らせ • Aug 24Novanta Inc. Announces Executive ChangesOn August 22, 2024, John Burke, formerly Vice President of Global Accounting for Novanta Inc. (company) was appointed Chief Accounting Officer of the company and assumed the role of principal accounting officer. Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024. Mr. Chang, who served thirteen years in the role, will serve as an advisor to the Chief Financial Officer until his anticipated departure from the Company on February 28, 2025, and will assist with the transition of the Chief Accounting Officer role. Mr. Burke, age 43, has been it’s Vice President of Global Accounting since 2021, and previously served as Vice President of Accounting from 2017 to 2021 and Assistant Corporate Controller from 2011 to 2017. Prior to joining the company, Mr. Burke worked as the Manager of Technical Accounting and Reporting at MilliporeSigma (formerly known as Millipore Corporation), and prior to that, as an audit manager in the Boston office of PricewaterhouseCoopers LLP. Mr. Burke is a Certified Public Accountant and has a Bachelor of Business Administration degree in Accounting from the University of Massachusetts-Amherst.
Reported Earnings • Aug 07Second quarter 2024 earnings released: EPS: US$0.38 (vs US$0.58 in 2Q 2023)Second quarter 2024 results: EPS: US$0.38 (down from US$0.58 in 2Q 2023). Revenue: US$235.9m (up 2.8% from 2Q 2023). Net income: US$13.8m (down 34% from 2Q 2023). Profit margin: 5.8% (down from 9.1% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 07Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024Novanta Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, Company expects GAAP revenue of approximately $241 millionto $244 million. For the year, the company expects GAAP revenue of approximately $975 million, representing reported revenue growth of greater than 10%.
お知らせ • Jul 10Novanta Inc. to Report Q2, 2024 Results on Aug 06, 2024Novanta Inc. announced that they will report Q2, 2024 results on Aug 06, 2024
お知らせ • May 08Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2024Novanta Inc. provided earnings guidance for the second quarter of 2024. For the quarter, the Company expects GAAP revenue of approximately $230 million to $235 million.
Reported Earnings • May 07First quarter 2024 earnings released: EPS: US$0.41 (vs US$0.51 in 1Q 2023)First quarter 2024 results: EPS: US$0.41 (down from US$0.51 in 1Q 2023). Revenue: US$230.9m (up 5.4% from 1Q 2023). Net income: US$14.7m (down 20% from 1Q 2023). Profit margin: 6.4% (down from 8.3% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 13% per year.
お知らせ • Apr 10Novanta Inc. to Report Q1, 2024 Results on May 07, 2024Novanta Inc. announced that they will report Q1, 2024 results at 12:30 PM, US Eastern Standard Time on May 07, 2024
お知らせ • Mar 01Novanta Inc., Annual General Meeting, May 08, 2024Novanta Inc., Annual General Meeting, May 08, 2024.
お知らせ • Feb 29Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024Novanta Inc. provided revenue guidance for the first quarter and full year of 2024. For the quarter, company expects GAAP revenue of approximately $225 million to $230 million. For the year, Company expects GAAP revenue of approximately $975 million to $1 billion.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: US$2.03 (vs US$2.08 in FY 2022)Full year 2023 results: EPS: US$2.03 (down from US$2.08 in FY 2022). Revenue: US$881.7m (up 2.4% from FY 2022). Net income: US$72.9m (down 1.6% from FY 2022). Profit margin: 8.3% (down from 8.6% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 30Novanta Inc. to Report Q4, 2023 Results on Feb 28, 2024Novanta Inc. announced that they will report Q4, 2023 results on Feb 28, 2024
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €132, the stock trades at a forward P/E ratio of 63x. Average forward P/E is 11x in the Electronic industry in Germany. Total returns to shareholders of 38% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €86.58 per share.
お知らせ • Nov 09Novanta Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Full Year 2023Novanta Inc. provides revenue guidance for the fourth quarter of 2023 and full year 2023. For the fourth quarter of 2023, the Company expects GAAP revenue of approximately $208 million to $212 million. For the full year 2023, the Company expects GAAP revenue of approximately $878 million to $882 million.
Reported Earnings • Nov 08Third quarter 2023 earnings released: EPS: US$0.59 (vs US$0.63 in 3Q 2022)Third quarter 2023 results: EPS: US$0.59 (down from US$0.63 in 3Q 2022). Revenue: US$221.5m (flat on 3Q 2022). Net income: US$21.2m (down 5.6% from 3Q 2022). Profit margin: 9.6% (in line with 3Q 2022). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 11Novanta Inc. to Report Q3, 2023 Results on Nov 07, 2023Novanta Inc. announced that they will report Q3, 2023 results on Nov 07, 2023
Reported Earnings • Aug 09Second quarter 2023 earnings released: EPS: US$0.58 (vs US$0.49 in 2Q 2022)Second quarter 2023 results: EPS: US$0.58 (up from US$0.49 in 2Q 2022). Revenue: US$229.5m (up 6.6% from 2Q 2022). Net income: US$20.9m (up 20% from 2Q 2022). Profit margin: 9.1% (up from 8.1% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 09Second quarter 2023 earnings released: EPS: US$0.58 (vs US$0.49 in 2Q 2022)Second quarter 2023 results: EPS: US$0.58 (up from US$0.49 in 2Q 2022). Revenue: US$229.5m (up 6.6% from 2Q 2022). Net income: US$20.9m (up 20% from 2Q 2022). Profit margin: 9.1% (up from 8.1% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 09Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2023Novanta Inc. provided earnings guidance for the third quarter and full year 2023. For the quarter, the Company expects GAAP revenue of approximately $221 million to $224 million.For the full year 2023, the Company expects GAAP revenue of approximately $892 million to $902 million.
お知らせ • Jul 12Novanta Inc. to Report Q2, 2023 Results on Aug 08, 2023Novanta Inc. announced that they will report Q2, 2023 results at 9:30 AM, US Eastern Standard Time on Aug 08, 2023
お知らせ • May 10Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2023Novanta Inc. provided earnings guidance for the second quarter of 2023. For the quarter, the company expects GAAP revenue of approximately $222 million to $225 million.
Reported Earnings • May 10First quarter 2023 earnings released: EPS: US$0.51 (vs US$0.53 in 1Q 2022)First quarter 2023 results: EPS: US$0.51 (down from US$0.53 in 1Q 2022). Revenue: US$219.1m (up 7.3% from 1Q 2022). Net income: US$18.3m (down 2.9% from 1Q 2022). Profit margin: 8.3% (down from 9.2% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 22% per year.
Reported Earnings • Mar 02Full year 2022 earnings released: EPS: US$2.08 (vs US$1.42 in FY 2021)Full year 2022 results: EPS: US$2.08 (up from US$1.42 in FY 2021). Revenue: US$860.9m (up 22% from FY 2021). Net income: US$74.1m (up 47% from FY 2021). Profit margin: 8.6% (up from 7.1% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 18% per year.
お知らせ • Feb 02Novanta Inc. to Report Q4, 2022 Results on Mar 01, 2023Novanta Inc. announced that they will report Q4, 2022 results on Mar 01, 2023
Board Change • Nov 16High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Barbara Hulit was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 09Third quarter 2022 earnings released: EPS: US$0.63 (vs US$0.38 in 3Q 2021)Third quarter 2022 results: EPS: US$0.63 (up from US$0.38 in 3Q 2021). Revenue: US$223.0m (up 26% from 3Q 2021). Net income: US$22.5m (up 65% from 3Q 2021). Profit margin: 10% (up from 7.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 09Novanta Inc. Provides Financial Guidance for the Fourth Quarter and Full Year 2022Novanta Inc. provided financial guidance for the fourth quarter and full year 2022. For the fourth quarter of 2022, the Company expects GAAP revenue of approximately $215 million to $217 million, demonstrating reported growth of 8% to 9%. For the full year 2022, the Company expects GAAP revenue of approximately $857 million to $859 million, demonstrating reported growth of 21% to 22%.
お知らせ • Oct 22Novan, Inc., Epi Health and MC2 Therapeutics Present New Data in Multiple Posters Highlighting Wynzora’s Unique Pad Technology At the 42Nd Annual Fall Clinical Dermatology ConferenceNovan Inc. EPI Health and MC2 Therapeutics announced positive data demonstrating the impact of PAD Technology™ in WYNZORA® Cream in three posters featured at the 42nd Annual Fall Clinical Dermatology Conference® taking place October 20-23, 2022, in Las Vegas, NV. PAD Technology™, as explained in one of the posters, is a proprietary topical formulation and drug delivery system that allows CAL and BDP to co-exist in an aqueous environment (WYNZORA® Cream), for the first time.1 These active ingredients are stable at different pH levels, and without the unique properties of PAD Technology™ could not co-exist in a water-based formulation. In a second poster, diffusion of these active ingredients through human epidermis was investigated in an in vitro Franz diffusion study. This demonstrated that consistently higher amounts of CAL and BDP diffused through the epidermis with the PAD Technology™ based cream compared with the CAL/BDP topical suspension. The results were statistically significant in favor of CAL/BDP cream vs. CAL/BDP topical suspension (p<0.05) at all time points for both actives. Finally, WYNZORA® cream was compared to CAL/BDP topical suspension in a deposition study in 10 healthy human volunteers using tape strips taken at 1, 2, 4 and 8 hours. The results showed that more BDP was delivered to the stratum corneum and epidermis with the PAD Technology™-driven cream formulation than with the CAL/BDP topical suspension at every time point. EPI Health, a Novan company, and MC2 Therapeutics jointly market MC2 Therapeutics' WYNZORA® (calcipotriene and betamethasone dipropionate) Cream in the US, a once-daily aqueous cream that combines the benefits of a high potency steroid plus Vitamin D for the treatment of plaque psoriasis. WYNZORA® Cream demonstrates a rapid onset of action with results seen in efficacy, scale and itch as early as 1 week and continued improvement at 8 weeks.2,3 Under a Promotion and Collaboration Agreement between EPI Health and MC2 Therapeutics, EPI Health has exclusive detailing and distribution rights and the right to jointly with MC2 Therapeutics engage in promotional, regulatory and certain commercialization activities for WYNZORA® Cream in the United States.
お知らせ • Oct 11Novanta Inc. to Report Q3, 2022 Results on Nov 08, 2022Novanta Inc. announced that they will report Q3, 2022 results on Nov 08, 2022
Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: US$0.49 (vs US$0.33 in 2Q 2021)Second quarter 2022 results: EPS: US$0.49 (up from US$0.33 in 2Q 2021). Revenue: US$215.4m (up 29% from 2Q 2021). Net income: US$17.5m (up 50% from 2Q 2021). Profit margin: 8.1% (up from 7.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11%, compared to a 21% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 10Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022Novanta Inc. provided earnings guidance for the third quarter and full year 2022. For the quarter, the company expects GAAP revenue of approximately $214 million to $216 million, demonstrating reported growth of 20% to 22%.For the year, the company expects GAAP revenue of approximately $848 million to $852 million, demonstrating reported growth of 20% to 21%.
Board Change • Aug 01High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Barbara Hulit was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jul 28Novanta Inc. Announces Director ChangesOn July 26, 2022, Ira J. Lamel resigned as a director of Novanta Inc. effective immediately. On July 26, 2022, the Board of Directors of the Company elected Barbara B. Hulit to the Board to fill an existing vacancy, effective July 26, 2022. Ms. Hulit will also serve as a member of the Environmental, Social and Governance Committee of the Board.
お知らせ • Jul 12+ 1 more updateNovanta Inc. to Report Q2, 2022 Results on Aug 09, 2022Novanta Inc. announced that they will report Q2, 2022 results on Aug 09, 2022
Board Change • Jul 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Darlene J. Solomon was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 29Novanta Inc. Announces Directorate ChangesNovanta Inc. announced that on June 28, 2022, Brian King resigned as a director of the company, effective immediately. On June 28, 2022, the Board of Directors of the Company elected Darlene J. S. Solomon, Ph.D., to the Board to fill an existing vacancy, effective June 28, 2022. Ms. Solomon will also serve as a member of the Compensation Committee of the Board.
お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2022Novanta Inc. provided earnings guidance for the second quarter of 2022. The Company expects GAAP revenue of approximately $205 million to $213 million, demonstrating reported growth of 22% to 27%.
Reported Earnings • May 11First quarter 2022 earnings released: EPS: US$0.53 (vs US$0.32 in 1Q 2021)First quarter 2022 results: EPS: US$0.53 (up from US$0.32 in 1Q 2021). Revenue: US$204.2m (up 26% from 1Q 2021). Net income: US$18.8m (up 66% from 1Q 2021). Profit margin: 9.2% (up from 7.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 27% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Apr 12Novanta Inc. to Report Q1, 2022 Results on May 10, 2022Novanta Inc. announced that they will report Q1, 2022 results on May 10, 2022
お知らせ • Mar 04Novanta Inc., Annual General Meeting, May 12, 2022Novanta Inc., Annual General Meeting, May 12, 2022.
Reported Earnings • Mar 03Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: US$1.42 (up from US$1.27 in FY 2020). Revenue: US$706.8m (up 20% from FY 2020). Net income: US$50.3m (up 13% from FY 2020). Profit margin: 7.1% (down from 7.5% in FY 2020). Revenue exceeded analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 17%, compared to a 23% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
お知らせ • Mar 03Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year 2022Novanta Inc. provided revenue guidance for the first quarter and full year 2022. For the quarter, the Company expects GAAP revenue to be in the range of approximately $192 million to $200 million. For the full year 2022, the Company expects GAAP revenue to be in the range of approximately $825 million to $845 million.
Reported Earnings • Nov 11Third quarter 2021 earnings released: EPS US$0.38 (vs US$0.23 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$177.7m (up 24% from 3Q 2020). Net income: US$13.6m (up 65% from 3Q 2020). Profit margin: 7.7% (up from 5.8% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 11Second quarter 2021 earnings released: EPS US$0.33 (vs US$0.33 in 2Q 2020)The company reported a mediocre second quarter result with weaker profit margins, although earnings were flat and revenues improved. Second quarter 2021 results: Revenue: US$167.5m (up 16% from 2Q 2020). Net income: US$11.7m (flat on 2Q 2020). Profit margin: 7.0% (down from 8.1% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 20Novanta Inc. (NasdaqGS:NOVT) entered into an agreement to acquire ATI Industrial Automation, Inc. for approximately $170 million.Novanta Inc. (NasdaqGS:NOVT) entered into an agreement to acquire ATI Industrial Automation, Inc. for approximately $170 million on July 19, 2021. The consideration of $172 million will be paid upfront in cash and additional contingent cash payments associated with 2021 financial performance. The acquisition will be financed using available cash and Novanta's revolving credit facility. ATI's expected 2021 revenue will be greater than $70 million on a full year basis. ATI's actual revenue and profit contribution to Novanta's 2021 financial results will depend on the ultimate date of the closing of the transaction, among other factors. The transaction is subject to customary closing conditions, including regulatory approvals and termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2021. The acquisition is expected to be accretive to Novanta's free cash flow and non-GAAP earnings per share on a full year basis. John Arendale, Jeff Perkins, Brandt Carr, Jenson Dunn and Caroline Inglesby of Harris Williams LLC acted as financial advisor to ATI Industrial Automation.
Reported Earnings • May 13First quarter 2021 earnings released: EPS US$0.32 (vs US$0.34 in 1Q 2020)The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: US$162.6m (up 4.6% from 1Q 2020). Net income: US$11.3m (down 5.3% from 1Q 2020). Profit margin: 7.0% (down from 7.7% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2021Novanta Inc. provided earnings guidance for the second quarter and full year 2021. For the second quarter of 2021, the Company expects GAAP revenue of approximately $162 million to $165 million. For the full year 2021, the Company expects GAAP revenue of approximately $645 million to $655 million.
Reported Earnings • Mar 03Full year 2020 earnings released: EPS US$1.27 (vs US$1.16 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: US$590.6m (down 5.7% from FY 2019). Net income: US$44.5m (up 9.2% from FY 2019). Profit margin: 7.5% (up from 6.5% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.
Analyst Estimate Surprise Post Earnings • Mar 03Revenue beats expectationsRevenue exceeded analyst estimates by 0.08%. Over the next year, revenue is forecast to grow 8.7%, compared to a 17% growth forecast for the Electronic industry in Germany.
お知らせ • Feb 27Novanta Inc., Annual General Meeting, May 13, 2021Novanta Inc., Annual General Meeting, May 13, 2021.
Is New 90 Day High Low • Feb 13New 90-day high: €117The company is up 22% from its price of €96.00 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €34.81 per share.
お知らせ • Feb 03Novanta Inc. to Report Q4, 2020 Results on Mar 01, 2021Novanta Inc. announced that they will report Q4, 2020 results on Mar 01, 2021
Is New 90 Day High Low • Jan 26New 90-day high: €110The company is up 15% from its price of €95.50 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.26 per share.
Is New 90 Day High Low • Jan 09New 90-day high: €105The company is up 9.0% from its price of €96.50 on 09 October 2020. The German market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Electronic industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €34.77 per share.
お知らせ • Dec 23Novan, Inc. Enters into a Master Services Agreement (MSA) with CatalentNovan, Inc. announced it has entered into a Master Services Agreement (MSA) with Catalent, which will include support of chemistry, manufacturing and control (CMC) activities and development of an intranasal formulation of berdazimer sodium for use in the Company’s coronavirus (COVID-19) program. Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Catalent’s advanced formulation development and manufacturing spans a range of technologies, along with integrated downstream clinical development and commercial supply solutions. Novan initiated in vitro assessments of its NITRICIL™ platform against the novel SARS-CoV-2 coronavirus, targeting the reduction of viral burden in differentiated normal human bronchial epithelial cells. The studies were conducted at the Institute for Antiviral Research at Utah State University, and these results demonstrated the first instance of an antiviral effect from a nitric oxide-based medicine in a 3-D tissue model that has similar structure to the human airway epithelium. The results from the in vitro assessment of concentrations as low as 0.75 mg/mL demonstrated that berdazimer sodium reduced 90% of virus after repeat dosing, once daily. Based on the scientific literature and data available to-date with berdazimer sodium and Novan’s product candidate SB206, Novan believes that nitric oxide may inhibit viral replication by disrupting protein function critical for viral replication and infection through generation of reactive intermediates. Following the completion of preclinical studies, Novan is targeting filing a potential IND application with the U.S. Food and Drug Administration and, subject to obtaining additional funding, targets initiating human clinical trials in the second half of 2021.
お知らせ • Dec 13Novanta Inc. Elects Katherine A. Owen to the Board, Effective February 24, 2021On December 8, 2020, the Board of Directors of Novanta Inc. elected Katherine A. Owen to the Board, effective February 24, 2021, to fill an existing vacancy on the Board.
Analyst Estimate Surprise Post Earnings • Nov 11Revenue beats expectationsRevenue exceeded analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 4.2%, compared to a 24% growth forecast for the Electronic industry in Germany.
Reported Earnings • Nov 11Third quarter 2020 earnings released: EPS US$0.23The company reported a poor third quarter result with weaker earnings and revenues, although profit margins were flat. Third quarter 2020 results: Revenue: US$142.9m (down 7.2% from 3Q 2019). Net income: US$8.26m (down 7.5% from 3Q 2019). Profit margin: 5.8% (in line with 3Q 2019). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Is New 90 Day High Low • Nov 07New 90-day high: €100.00The company is up 4.0% from its price of €96.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €35.48 per share.
お知らせ • Oct 15Novanta Inc. to Report Q3, 2020 Results on Nov 10, 2020Novanta Inc. announced that they will report Q3, 2020 results at 11:59 AM, GMT Standard Time on Nov 10, 2020
お知らせ • Aug 24Novanta Inc. Not Able to Reliably Estimate the Future Impact on its Operations and Other Financial Results for the Full Year 2020Novanta Inc. announced that due to the impact of the COVID-19 pandemic, the uncertain duration and scope of the pandemic, and the uncertain timing of the global public health and economic recovery, the Company is not able at this time to reliably estimate the future impact on its operations and other financial results for the full year 2020.
お知らせ • Jul 17Novanta Inc. to Report Q2, 2020 Results on Aug 06, 2020Novanta Inc. announced that they will report Q2, 2020 results at 11:59 AM, GMT Standard Time on Aug 06, 2020
お知らせ • Jul 02Novanta Inc.(NasdaqGS:NOVT) dropped from Russell 2000 Dynamic IndexNovanta Inc.(NasdaqGS:NOVT) dropped from Russell 2000 Dynamic Index
